Hong Kong Renewable Energy Stock News

Global markets have recently experienced a boost in investor sentiment, driven by a ceasefire agreement between the U.S. and Iran, which has helped ease geopolitical tensions and lower oil prices. As major indices like the Nasdaq Composite see significant gains, investors are increasingly looking for opportunities that balance risk with potential rewards. Though "penny stocks" might seem like an outdated term, they continue to offer intriguing prospects for growth. These stocks often...

Skyworth Group (SEHK:751) recently drew investor interest after its shares closed at HK$6.42, with a one day return of 2.1% and a year to date return of 23.9%, spotlighting its diversified electronics and new energy operations. See our latest analysis for Skyworth Group. That 2.1% one day share price return and 4.1% 7 day share price return sit against a softer 30 day share price return of an 8.6% decline, while the 1 year total shareholder return of 126.1% points to momentum that has been...

Insiders at Legend Strategy International Holdings Group Company Limited ( HKG:1355 ) sold HK$69m worth of stock at an...

Ficus Technology Holdings Limited's (HKG:8107) value has fallen 16% in the last week, but insiders who sold HK$3.0m...

Looking at Feiyang International Holdings Group Limited's ( HKG:1901 ) insider transactions over the last year, we can...

The recent price decline of 12% in Kwan On Holdings Limited's ( HKG:1559 ) stock may have disappointed insiders who...

OSL Group recently welcomed the Hong Kong Monetary Authority’s announcement of the first stablecoin issuer licensees and highlighted its integration of travel rule solutions to support compliant transaction identity sharing in stablecoin trading and payments. By positioning itself as a regulatory compliance benchmark and a stablecoin trading and payment hub in Asia, OSL is emphasizing its intent to be central to Hong Kong’s emerging licensed stablecoin ecosystem. Now we’ll examine how OSL’s...

Finsoft Financial Investment Holdings Limited ( HKG:8018 ) insiders who bought shares over the past year were rewarded...

China Jinmao Holdings Group (SEHK:817) is back in focus after Jinmao Property Services signed a multi year Car Parks Leasing Framework Agreement with related parties, setting out sizable caps and detailed internal safeguards. See our latest analysis for China Jinmao Holdings Group. At a latest share price of HK$1.51, China Jinmao Holdings Group has seen a 22.76% year to date share price return, with a 30.40% 1 year total shareholder return suggesting momentum has been building ahead of the...

While SANVO Fine Chemicals Group Limited ( HKG:301 ) shareholders have had a good week with the stock up 13%, they...

Why Agricultural Bank of China Stock Is On Investors’ Radar Agricultural Bank of China (SEHK:1288) has recently drawn attention after a period of strong total returns, with the stock showing double digit gains over the past year and past three years. See our latest analysis for Agricultural Bank of China. Recent trading points to momentum building, with a 16% 1 month share price return and a 38% 1 year total shareholder return coming on top of a very large 3 year total shareholder return. If...

As global markets respond positively to a U.S.-Iran ceasefire, investor sentiment has improved, leading to gains across major indices. In this context, penny stocks—often representing smaller or newer companies—can still offer intriguing opportunities for growth when backed by solid financial health. Despite being considered a niche investment area today, these stocks can provide value and potential upside for those looking beyond larger firms.

Aluminum Corporation of China (SEHK:2600) issued first quarter 2026 earnings guidance, flagging net profit of CN¥5,302 million to CN¥5,585 million and basic EPS of CN¥0.310 to CN¥0.326, both implying 50% to 58% year-on-year growth. See our latest analysis for Aluminum Corporation of China. The earnings guidance comes after a sharp re-rating, with the 1-year total shareholder return of about 3x and a more muted share price return of 0.32% year to date at HK$12.68. Recent 7-day strength...

Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting the first patient enrollment in a Phase II trial in China for LY03020, a dual TAAR1 and 5-HT2CR agonist targeting schizophrenia. See our latest analysis for Luye Pharma Group. The LY03020 trial update comes as Luye Pharma Group’s share price sits at HK$2.89, with a 30-day share price return of 18.93% contrasting with a 90-day share price decline of 3.99%. The 1-year total shareholder return of 55.38% stands against a...

Why Xiaomi’s stock is drawing fresh attention Xiaomi (SEHK:1810) is back on investors’ radar after recent trading left the share price lower over the past month and the past 3 months, prompting closer scrutiny of its current valuation and business mix. See our latest analysis for Xiaomi. At the latest share price of HK$30.88, Xiaomi’s recent 30 day share price return of 7.32% and year to date share price return of 23.34% contrast with a 3 year total shareholder return of 148.23%. This...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Renewed agreements with Yili Group set the context China Youran Dairy Group (SEHK:9858) has renewed long term supply and financial agreements with controlling shareholder Yili Group. These agreements lock in their commercial relationship from 2027 to 2029 and formalize ongoing raw milk and dairy product transactions. See our latest analysis for China Youran Dairy Group. The renewed Yili contracts arrive after a weaker patch for the shares, with a 30 day share price return of 5.58% and a 90...

China Shenhua Energy (SEHK:1088) has drawn investor attention after reporting its 2025 results, proposing a sizeable final dividend, and outlining detailed 2026 production and sales guidance alongside sector interest in anthracite market growth. See our latest analysis for China Shenhua Energy. The recent dividend proposal and 2026 guidance land at a time when the share price is HK$45.4, with recent 1 month and 7 day share price returns softer. However, a 1 year total shareholder return of...

Dongfang Electric (SEHK:1072) has drawn fresh attention after reporting full year 2025 results alongside a declared final ordinary dividend of RMB 5.3 per 10 shares, providing both earnings and income updates for shareholders. See our latest analysis for Dongfang Electric. The full year results and higher dividend have arrived against a strong backdrop, with a 90 day share price return of 60.83% and a very large 1 year total shareholder return that far outpaces the short term moves. If...

Central New Energy Holding Group (SEHK:1735) reported full year 2025 results, with sales of HK$11,016.85 million, net income of HK$34.24 million, and earnings per share of HK$0.0081 from continuing operations. See our latest analysis for Central New Energy Holding Group. The earnings release comes after a steady run in the shares, with a 9.55% 1 month share price return and 12.30% 3 month share price return. However, the 1 year total shareholder return is still down 6.58% while the 5 year...

Genscript Biotech (SEHK:1548) is back in focus after announcing a multi year collaboration with Mimulus Corp to industrialize DNA based data storage, targeting scalable infrastructure and substantial cost efficiencies by 2030. See our latest analysis for Genscript Biotech. The collaboration headlines come as Genscript Biotech's share price, now at HK$12.62, shows mixed momentum, with a 13.8% 1 month share price return but a 12.42% decline over 3 months. The 1 year total shareholder return...

Zhejiang Expressway Co., Ltd. recently reported its full-year 2025 results, with sales rising to CNY 19.76 billion while net income eased slightly to CNY 5.32 billion, and recommended a higher dividend of CNY 0.395 per share, all subject to approval at the 2025 annual shareholders’ meeting. The combination of revenue growth, a modest earnings dip and a proposed dividend increase highlights management’s emphasis on returning cash to shareholders while operating profitability remains under...

Akeso (SEHK:9926) has come into focus after presenting new lung cancer data at the 2026 European Lung Cancer Congress. The company updated investors on cadonilimab and ivonescimab across difficult non small cell lung cancer settings. See our latest analysis for Akeso. Following the ELCC updates, Akeso's HK$137.8 share price sits on the back of a 25.05% 1 month share price return and 21.62% year to date share price return. The 1 year total shareholder return of 58.48% and 3 year total...

Why the latest results matter for Sinotrans shareholders Sinotrans (SEHK:598) has just reported full year 2025 earnings, with revenue lower than the previous year but higher net income and earnings per share, alongside a proposed final ordinary dividend of RMB 0.155 per share. See our latest analysis for Sinotrans. The latest figures and proposed dividend come after a relatively steady share price, with Sinotrans at HK$4.99 and modest short term moves but very strong 1 year and multi year...